Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908733-07-000183
Filing Date
2007-01-12
Accepted
2007-01-12 10:59:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 COLLAGENEX PHARMACEUTICALS INC 13G collagenexpharmaceuticals.htm SC 13G 11628
  Complete submission text file 0000908733-07-000183.txt   13841
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47825 | Film No.: 07527353
SIC: 2834 Pharmaceutical Preparations